Dr. Michael Baird, M.D

NPI: 1346252459
Total Payments
$3,647
2024 Payments
$98.89
Companies
18
Transactions
208
Medicare Patients
494
Medicare Billing
$66,068

Payment Breakdown by Category

Food & Beverage$3,556 (97.5%)
Education$91.25 (2.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,556 204 97.5%
Education $91.25 4 2.5%

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $745.90 54 $0 (2023)
Janssen Biotech, Inc. $740.87 30 $0 (2023)
ABBVIE INC. $485.33 36 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $381.17 25 $0 (2024)
GENZYME CORPORATION $236.33 8 $0 (2023)
Ardelyx, Inc. $204.20 12 $0 (2023)
Regeneron Healthcare Solutions, Inc. $190.27 7 $0 (2023)
QOL Medical, LLC $173.45 7 $0 (2022)
RedHill Biopharma Inc. $167.67 9 $0 (2023)
NESTLE HEALTHCARE NUTRITION INC. $107.87 6 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $98.89 5 IRONWOOD PHARMACEUTICALS, INC ($32.07)
2023 $1,634 87 Janssen Biotech, Inc. ($554.88)
2022 $1,560 93 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($391.91)
2021 $353.91 23 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($164.55)

All Payment Transactions

208 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/18/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $14.09 General
Category: GI
11/13/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $17.98 General
Category: GI
09/25/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $27.40 General
Category: IMMUNOLOGY
07/24/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $20.67 General
Category: INTERNAL MEDICINE
05/29/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $18.75 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/01/2023 AbbVie Inc. LINZESS (Drug), VIBERZI, CREON Food and Beverage In-kind items and services $13.50 General
Category: GASTROENTEROLOGY
11/29/2023 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $10.86 General
Category: GASTROENTEROLOGY
11/10/2023 Janssen Scientific Affairs, LLC Food and Beverage In-kind items and services $15.97 General
11/10/2023 AbbVie Inc. VIBERZI (Drug), LINZESS Food and Beverage In-kind items and services $2.92 General
Category: GASTROENTEROLOGY
11/09/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $122.78 General
Category: Immunology
11/09/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $28.61 General
Category: Immunology
11/09/2023 Ironwood Pharmaceuticals, Inc Linzess (Drug) Food and Beverage Cash or cash equivalent $14.16 General
Category: GI
11/03/2023 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $10.83 General
Category: GASTROENTEROLOGY
11/01/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $18.77 General
Category: Gastroenterology
10/31/2023 Janssen Biotech, Inc. REMICADE (Biological), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $16.56 General
Category: Immunology
10/26/2023 AbbVie Inc. VIBERZI (Drug), LINZESS Food and Beverage In-kind items and services $17.05 General
Category: GASTROENTEROLOGY
10/24/2023 Ironwood Pharmaceuticals, Inc Linzess (Drug) Food and Beverage Cash or cash equivalent $14.40 General
Category: GI
10/24/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.14 General
Category: Gastroenterology
10/24/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $4.40 General
Category: Gastroenterology
10/18/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $26.43 General
Category: Immunology
10/17/2023 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $31.24 General
Category: Immunology
10/17/2023 Evoke Pharma, Inc. GIMOTI (Drug) Food and Beverage In-kind items and services $13.14 General
Category: Gastroenterology
10/13/2023 Regeneron Healthcare Solutions, Inc. Food and Beverage In-kind items and services $41.43 General
10/04/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $8.33 General
Category: Gastroenterology
09/29/2023 AbbVie Inc. VIBERZI (Drug), LINZESS Food and Beverage In-kind items and services $11.62 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 196 279 $249,000 $28,498
2022 6 249 328 $193,865 $32,403
2021 3 49 54 $13,675 $5,167
Total Patients
494
Total Services
661
Medicare Billing
$66,068
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 91 166 $41,500 $15,235 36.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 48 55 $82,500 $5,437 6.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 39 40 $80,000 $4,295 5.4%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 18 18 $45,000 $3,530 7.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 106 178 $40,525 $15,802 39.0%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 51 52 $63,000 $6,276 10.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 47 49 $44,100 $5,078 11.5%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 11 12 $39,600 $2,335 5.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 23 26 $3,440 $1,616 47.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 11 11 $3,200 $1,295 40.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 25 30 $4,950 $3,036 61.3%
43239 Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope Facility 2021 11 11 $7,425 $1,205 16.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 13 13 $1,300 $925.60 71.2%

About Dr. Michael Baird, M.D

Dr. Michael Baird, M.D is a Gastroenterology healthcare provider based in Sheboygan, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346252459.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Baird, M.D has received a total of $3,647 in payments from pharmaceutical and medical device companies, with $98.89 received in 2024. These payments were reported across 208 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,556).

As a Medicare-enrolled provider, Baird has provided services to 494 Medicare beneficiaries, totaling 661 services with total Medicare billing of $66,068. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Gastroenterology
  • Location Sheboygan, WI
  • Active Since 08/13/2006
  • Last Updated 06/24/2010
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1346252459

Products in Payments

  • STELARA (Biological) $509.22
  • XIFAXAN (Drug) $475.86
  • DUPIXENT (Biological) $385.17
  • Linzess (Drug) $381.17
  • LINZESS (Drug) $257.99
  • REMICADE (Biological) $231.65
  • IBSRELA (Drug) $204.20
  • TRULANCE (Drug) $203.28
  • SUCRAID (Drug) $173.45
  • Talicia (Drug) $144.78
  • ZENPEP (Drug) $107.87
  • VIBERZI (Drug) $88.34
  • CREON (Drug) $86.92
  • RELISTOR (Drug) $66.76
  • GIMOTI (Drug) $56.26
  • DIFICID (Drug) $45.17
  • RINVOQ (Biological) $27.40
  • MAVYRET (Drug) $24.68
  • Movantik (Drug) $22.89
  • ENTYVIO (Biological) $20.67

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Sheboygan